Consistently, TRPV1 activation reportedly protects against renal damage during hypertension as TRPV1 loss promotes the upregulation of fibronectin, expression of type I and III collagen, which can delay the progression of interstitial renal fibrosis. Here, TRPV1 is linked to hypertensive disorder.